Drug intelligence / Profile preview

levothyroxine sodium

Development stage
Approved
Lead developer
Abbott
Modality
Small Molecules
Administration
Oral
01

Overview

Levothyroxine sodium is a synthetic version of the thyroid hormone thyroxine (T4) used primarily to treat hypothyroidism, a condition where the thyroid gland doesn't produce enough thyroid hormone. It's also used in the management of thyroid cancer alongside surgery and radioactive iodine therapy[1][2][3]. The medication works by replacing the thyroid hormone that would normally be produced by the body[1][2]. Without adequate thyroid hormone, the body cannot function properly, leading to symptoms such as poor growth, slow speech, lack of energy, excessive tiredness, constipation, weight gain, hair loss, dry skin, increased cold sensitivity, joint and muscle pain, irregular menstrual periods, and depression[1][2]. Levothyroxine sodium is available in multiple formulations including tablets, soft gel capsules, and oral solutions[9]. In the United States, there are several brand-name products including Synthroid, Levoxyl, Levo-T, Unithroid, Tirosint, Euthyrox, and Levothroid[2][6][9]. Generic versions are also widely available, with generic prescriptions accounting for 84.9% of thyroid hormone prescription fills as of 2016[9]. The medication has a narrow therapeutic index, meaning the effective dose is close to the toxic dose, so careful dosing and monitoring are essential[8]. Treatment is typically monitored through blood tests measuring thyroid stimulating hormone (TSH) levels, with the goal of maintaining TSH within a therapeutic range of 0.4-4.0 mIU/L[8]. Levothyroxine sodium should not be used for weight loss or obesity treatment, as doses beyond the range of daily hormonal requirements can produce serious or even life-threatening toxicity[5][1].

Brand names
SynthroidLevoxylLevo-TUnithroidTirosintTirosint-SolEuthyroxLevothroidErmeza
Other names
levothyroxine
02

Targets

αVβ3 (Integrin αVβ3)THR (Thyroid hormone receptor)

Beyond the preview

Go deeper on levothyroxine sodium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on levothyroxine sodium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call